IP Library Granted Patent US 7,090,887
Granted Patent B2
US 7,090,887 · App. 10/255,599 · Granted Aug 15, 2006

Oilseed processing

Assignee: MCN Bioproducts Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,090,887
App. No.
10/255,599
Granted
Aug 15, 2006
Kind
B2
Abstract

Crushed and de-fatted oilseed is extracted with water at neutral, mildly basic or mildly acidic pH; and is filtered. The filter media allows passage of small fragments of solid cell meat into the filtrate. The filtrate is treated with a base to increase pH to over pH 9, and solids are separated out. Protein is separated from other constituents of the liquid and concentrated, for example by heat-induced or isoelectric precipitation and/or ultrafiltration. The remaining liquid is rich in sugars. The process results in one or more protein products suited for human or animal food ingredients or for production of cosmetics, a sugar rich product suitable for fermentation or use as a feed ingredient, and a fiber-protein animal feed ingredient.

Claims (15)

1. A process of treating detailed oilseed, which comprises:

(a) slurrying the detailed oilseed in water at a pH of 3–9 to create a slurry;

(b) separating the slurry into a first solid product and a first predominantly liquid fraction, and

(c) adding sufficient alkaline compound to the first predominantly liquid fraction to increase its pH to in excess of pH 9, whereby a second solid product precipitates from said first predominantly liquid fraction, leaving an alkaline second liquid fraction.

2. A process as claimed in claim 1 , in which the step of slurrying is carried out at a pH of 7–9.

3. A process as claimed in claim 2 , in which said first solid product comprises solids unable to pass through a screen having openings of 25 microns, but able to pass through a screen having openings of 2500 microns.

4. A process as claimed in claim 2 , in which sufficient alkaline compound is added to the predominantly liquid fraction to increase the pH of said liquid fraction to a pH in the range 11–12.

5. A process as claimed in claim 4 , in which the alkaline compound is CaO.

6. A process as claimed in claim 4 , in which the alkaline compound is Ca(OH) 2 .

7. A process as set out in claim 2 , in which the slurry is heated to 50° C.–95° C. and is agitated for from 5 minutes to 2 hours before it is separated into said first solid product and said predominantly liquid fraction.

8. A process as claimed in claim 2 , including the additional steps of:

(d) separating out said precipitate from the predominantly liquid fraction, whereby to obtain a second solid product and a second liquid fraction,

(e) adding water and a sufficient amount of an acidic compound to said second solid product, to acidify the second solid product to a pH 1–5, whereby a portion of said second solid product dissolves in the water to form a third liquid and the remainder of the second solid product does not dissolve, and

(f) precipitating protein from said alkaline second liquid fraction, whereby to obtain a fourth solid precipitate which is rich in protein and a fourth liquid which remains after the precipitation.

9. A process as claimed in claim 8 , in which the fourth liquid is ultrafiltered to yield a protein rich retentate and a sugar-rich permeate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2012
From: MCN BIOPRODUCTS INC.
To: BUNGE GLOBAL INNOVATION, LLC
Reel/Frame 028256/0669 →
SECURITY AGREEMENT Recorded Feb 16, 2010
From: MCN BIOPRODUCTS INC.
To: FORAGEN TECHNOLOGIES LIMITED PARTNERSHIP; CIC ASSET MANAGEMENT INC.; FCC VENTURES, A DIVISION OF FARM CREDIT CANADA; GROWTHWORKS CANADIAN FUND LTD.; GROWTHWORKS COMMERCIALIZATION FUND INC.
Reel/Frame 023950/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2003
From: NEWKIRK, REX W.; MAENZ, DAVID D.; CLASSEN, HENRY L.
To: MCN BIOPRODUCTS INC.
Reel/Frame 013637/0040 →
Priority Claims (1)
CA 2363451 · Nov 20, 2001 · national
Continuity (1)
Related Publication 20030124222A1 · Jul 3, 2003